Latest filing published 05 Jun 2017 for Neurogene Inc., €51k.
Filing timeline
BuySaleInsider track record
David Main: trading record in brief
David Main is a declared insider of Neurogene Inc., with filings sourced from SEC (Form 4). Between 12 March 2014 and 5 June 2017, the trades on record add up to 9 filings.
Sales make up the whole of the open-market record (3 sales, €185k). Other entries cover 3 option exercises. Since January 2017: no purchases and 3 sales on the market.
The record was last updated on 5 June 2017 with an option exercise (€51k) in Neurogene Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David Main
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,000 shares@ US$9.6016.1% of flowCommon StockSEC:0001209191-17-037966:0
- 6,000 shares@ US$13.0021.9% of flowCommon StockSEC:0001209191-17-037966:1
- 6,000 shares@ US$9.6016.1% of flowCommon StockSEC:0001209191-17-037966:2
- 6,000 shares@ US$13.5922.8% of flowCommon StockSEC:0001209191-17-037966:3
- 3,625 shares@ US$9.609.7% of flowCommon StockSEC:0001209191-17-037966:4
- 3,625 shares@ US$13.1613.3% of flowCommon StockSEC:0001209191-17-037966:5
- 71,530 sharesCommon StockSEC:0001209191-14-020599:2
- 9,459 shares@ US$11.00Common Special Voting StockSEC:0001209191-14-020599:0
- 71,530 sharesCommon Special Voting StockSEC:0001209191-14-020599:1
9 of 9 declarations